2018 Annual Meeting | C75 - Safe and Appropriate Opioid Prescribing in Neurology

Date Monday 04/23/18

Time 01:00 PM - 03:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Shaheen E. Lakhan, MD, PhD, MEd, FAAN

Topic(s) General Neurology

Learning Objectives Participants should be able to describe acute pain, chronic pain, chronic opioid therapy, and opioid misuse, abuse, tolerance, dependency, and addiction; demonstrate the skills of safe opioid prescribing which reflect an understanding of assessing, mitigating, and managing opioid risks in the neurology patient population; interpret the results of a focused history and physical examination, targeted biopsychosocial assessments, and drug panel laboratory testing in the setting of opioid therapy; and demonstrate awareness of opioid misuse, abuse, tolerance, and dependency, and the biopsychosocial impact of addiction on patients and their families and caregivers.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Interpersonal and Communication Skills, Professionalism, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice

Program Tracks Advanced Practice Provider

Recommended Audience Trainee, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist

Teaching Styles Case-based, Didactic, Interactive, Audience Participation

Event Timeline
01:00 PM - 01:05 PM	Luncheon	Introduction Shaheen E. Lakhan, MD, PhD, MEd, FAAN
01:05 PM - 01:55 PM	Speaker	Safe and Appropriate Opioid Prescribing: Part One Shaheen E. Lakhan, MD, PhD, MEd, FAAN, Daniel L. Menkes, MD, FAAN
01:55 PM - 02:45 PM	Speaker	Safe and Appropriate Opioid Prescribing: Part Two Jennifer Ault, DO, PhD, PT, Shaheen E. Lakhan, MD, PhD, MEd, FAAN
02:45 PM - 03:00 PM	Q&A	Questions and Answers

Faculty Disclosures
Shaheen E. Lakhan, MD, PhD, MEd, FAAN	Dr. Lakhan has received personal compensation for serving as an employee of Zogenix, Fern Health, Thriveworks, The Learning Corp, TriNet, Click Therapeutics. Dr. Lakhan has received personal compensation in the range of $1,000,000+ for serving as a Consultant for Shaheen Lakhan, MD, PhD, LLC. Dr. Lakhan has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurocrine, Fern Health, Lin Health. Dr. Lakhan has received personal compensation in the range of $500,000-$999,999 for serving as an officer or member of the Board of Directors for Click Therapeutics, SpineThera. Dr. Lakhan has stock in Zogenix, NeuroSport, Click Therapeutics, SpineThera.
Daniel L. Menkes, MD, FAAN	An immediate family member of Dr. Menkes has received personal compensation for serving as an employee of NIH. An immediate family member of Dr. Menkes has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CMTE. An immediate family member of Dr. Menkes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. Dr. Menkes has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Self Employed. An immediate family member of Dr. Menkes has received research support from Helmsley Foundation . An immediate family member of Dr. Menkes has received intellectual property interests from a discovery or technology relating to health care.
Jennifer Ault, DO, PhD, PT	No disclosure on file

��ɫ��

��ɫ��